Affymax, Inc.
(NASDAQ:AFFY)|
12.38 +0.56 (4.74%) Dec 04 - Close |
|
|
|
After-Hours 12.40 +0.02 (0.16%) Thu, 4 Dec 2008 7:40 PM
- Compare AFFY with:
- View: Line | Candlestick
Company Profile
Affymax, Inc.
4001 Miranda Avenue
Palo Alto, CA 94304
United States - Map
Phone: (650) 812-8700
Fax: (650) 424-0832
Website: www.affymax.com
CEO: Arlene M. Morris
Employees: 151
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Developing novel peptide-based drug candidates
A biopharmaceutical company which is engaged in the development of novel peptide-based drugs candidates to improve the treatment of serious and often life-threatening condition.
Recent news for AFFY
-
First South Bancorp, Dime Community Bancshares and CorVel among 52-week lows
SmallCapInvestor.com - Dec 01 at 3:57 ET
-
Briefing.com - Nov 20 at 8:02 ET
-
Affymax Announces Another Favorable Data Monitoring Committee Review of Phase 3 Hematide Program
Business Wire - Nov 20 at 8:00 ET
-
Affymax, Inc. (AFFY) Executive Officer to Ring the NASDAQ Stock Market Closing Bell
GlobeNewswire - Nov 18 at 10:00 ET
-
Business Wire - Nov 17 at 8:00 ET
-
Affymax to Present at Lazard Capital Markets Conference
Business Wire - Nov 13 at 4:00 ET
-
Affymax to Webcast Analyst and Investor Event on November 20, 2008
Business Wire - Nov 13 at 9:00 ET
-
Business Wire - Nov 13 at 8:00 ET
-
EDGAR Online Financials - Nov 11 at 9:04 ET
-
New Star Analyst Rankings for AFFYMAX, INC.
StarMine - Nov 09 at 9:19 ET